Health Catalyst Sees FY2026 Sales $246.000M-$249.000M vs $260.780M Est

Benzinga Newsdesk www.benzinga.com Positive 84.7%

Neg 0% Neu 0% Pos 84.7%

Health Catalyst (NASDAQ:HCAT) sees FY2026 sales of $246.000 million-$249.000 million vs $260.780 million analyst estimate.